Traws Pharma (TRAW) Tops Q2 EPS by 27c
Get Alerts TRAW Hot Sheet
Join SI Premium – FREE
Traws Pharma (NASDAQ: TRAW) reported Q2 EPS of ($0.16), $0.27 better than the analyst estimate of ($0.43).
For earnings history and earnings-related data on Traws Pharma (TRAW) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- Huazhu Group Limited (HTHT) Tops Q2 EPS by 37c
- Bimergen Energy Corporation (BESS) Reports Q2 EPS of $0.22
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share